Abstract
A spontaneous murine metastatic tumor system was used as a model to assess the effects of a major surgical procedure on tumor‐specific immune reactivity and the growth of micrometastases. Any major surgical procedure resulted in impaired cell‐mediated cytotoxicity postoperatively and an increase in the number of gross pulmonary metastases. The use of an immunorestorative drug, Thiabendazole, in the perioperative period resulted in an improved cytotoxic response and a significant decrease in pulmonary metastases. Perioperative immunotherapy can be an effective adjunct to surgery in preventing the growth of micrometastatic foci. Cancer 43:945–951, 1979.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 945-951 |
| Number of pages | 7 |
| Journal | Cancer |
| Volume | 43 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1979 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery'. Together they form a unique fingerprint.
Cite this
Lundy, J., Lovett, E. J., Wolinsky, S. M., & Conran, P. (1979). Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery. Cancer, 43(3), 945-951. https://doi.org/10.1002/1097-0142(197903)43:3<945::AID-CNCR2820430324>3.0.CO;2-V